Park Ha Biological Technology Co., Ltd. (PHH)

1 member of Congress has disclosed 2 trades in Park Ha Biological Technology Co., Ltd. (PHH) via STOCK Act filings. The most recent disclosure was a sale by Seth Moulton on 29 February 2016. Aggregate disclosed activity totals roughly $16K in sales (midpoint estimates from bracketed disclosure amounts).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Price data is not available for PHH
This ticker may have been delisted, renamed, or is not publicly quoted, so no live price, statistics or chart can be shown. The congressional trades disclosed for it are listed below.

Congressional Trading Activity for PHH

2 transactions
Compliance: 50%
Seth Moulton29 Feb 20165 Jul 2016SaleStock$1,001 - $15,000N/A
Seth Moulton29 Feb 201614 May 2017SaleStock$1,001 - $15,000N/A

Stock Overview

Market Data

Market Cap

$9.96M

Volume

428.94K

Beta

-0.02

P/E Ratio

-0.53

Fundamentals

EPS

$-0.72

Div. Yield

-

Open

$0.39

Day Range

$0.38 – $0.42

Company Information

Sector
Consumer Defensive
Industry
Household & Personal Products
Exchange
NASDAQ · USD
Country
CN
CEO
Xiaoqiu Zhang
IPO Date
2005-01-19
Website
parkha.cn

Park Ha Biological Technology Co., Ltd., an investment holding firm, is primarily engaged in the creation and development of skincare products within the People's Republic of China. The company's operations are divided into two core areas: direct pro...

Earnings

Recent Quarters

Q1 201830 Jun
EPS$-1.07
Beat 20.9%
Q4 201731 Mar
EPS$-0.92
Miss 59.4%
Q3 201731 Dec
EPS$-1.50
Miss 1.9%
Q2 201730 Sept
EPS$-1.14
Miss 13.3%
Q1 201730 Jun
EPS$-0.86
Beat 13.2%
Q4 201631 Mar
EPS$-1.25
Miss 37.3%
Q3 201631 Dec
EPS$-2.48
Beat 21.7%
Q2 201630 Sept
EPS$-0.50
Miss 8.2%
Q1 201630 Jun
EPS$-0.22
Beat 19.6%
Q4 201531 Mar
EPS$-0.56
Miss 28.3%
Q3 201531 Dec
EPS$-0.92
Miss 53.9%
Q2 201530 Sept
EPS$-0.84
Beat 33.5%
Q1 201530 Jun
EPS$-1.21
Miss 15.1%
Q4 201431 Mar
EPS$0.35
Beat 37.2%
Q3 201431 Dec
EPS$-0.65
Beat 14.3%
Q2 201430 Sept
EPS$4.00
Beat 8.4%
Q1 201430 Jun
EPS$-1.02
Miss 15.6%
Q4 201331 Mar
EPS$-0.73
Miss 4.4%
Q3 201331 Dec
EPS$0.67
Miss 17.1%
Q2 201330 Sept
EPS$-0.91
Beat 27.9%
Q1 201330 Jun
EPS$1.39
Miss 0.7%
Q4 201231 Mar
EPS$0.79
Miss 33.6%
Q3 201231 Dec
EPS$0.89
Beat 39.4%
Q2 201230 Sept
EPS$-0.74
Miss 3.7%
Q1 201230 Jun
EPS$-1.00
Beat 32.8%
Q4 201131 Mar
EPS$1.30
Miss 32.6%
Q3 201131 Dec
EPS$0.23
Beat 49.2%
Q2 201130 Sept
EPS$-2.62
Beat 32.4%
Q1 201130 Jun
EPS$-0.73
Miss 87.5%
Q4 201031 Mar
EPS$0.84
Beat 4.8%
Q3 201031 Dec
EPS$3.09
Miss 33.0%
Q2 201030 Sept
EPS$-0.14
Miss 43.6%
Q1 201030 Jun
EPS$-2.39
Beat 13.5%
Q4 200931 Mar
EPS$0.14
Miss 22.9%
Q3 200931 Dec
EPS$1.73
Beat 31.1%
Q2 200930 Sept
EPS$-0.95
Miss 44.4%
Q1 200930 Jun
EPS$1.92
Miss 10.7%
Q4 200831 Mar
EPS$0.04
Miss 32.5%
Q3 200831 Dec
EPS$-3.96
Miss 12.2%
Q2 200830 Sept
EPS$-1.55
Beat 32.0%
Q1 200830 Jun
EPS$0.29
Miss 23.1%
Q4 200731 Mar
EPS$0.55
Beat 18.4%
Q3 200731 Dec
EPS$0.22
Miss 29.6%
Q2 200730 Sept
EPS$-0.69
Miss 61.0%
Q1 200730 Jun
EPS$-0.02
Miss 57.0%
Q4 200631 Mar
EPS$0.27
Beat 6.9%
Q3 200631 Dec
EPS$0.02
Beat 2.7%
Q2 200630 Sept
EPS$-0.13
Miss 1.0%
Q1 200630 Jun
EPS$0.02
Miss 31.4%
Q4 200531 Mar
EPS$-0.20
Beat 10.2%
Q3 200531 Dec
EPS$4.69
Beat 87.6%
Q2 200530 Sept
EPS$0.85
Miss 8.8%
Q1 200530 Jun
EPS$0.34
Beat 27.5%
Q4 200431 Mar
EPS$-4.75
Beat 23.7%
Q3 200431 Dec
EPS$0.67
Beat 6.2%
Q2 200430 Sept
EPS$1.10
Miss 3.5%
Q1 200430 Jun
EPS$1.27
Miss 6.6%
Q4 200331 Mar
EPS$0.39
Miss 2.8%
Q3 200331 Dec
EPS$1.01
Miss 30.3%
Q2 200330 Sept
EPS$1.52
Miss 10.1%
Q1 200330 Jun
EPS$1.33
Miss 12.5%
Q4 200231 Mar
EPS$1.46
Beat 18.7%
Q3 200231 Dec
EPS$1.59
Beat 78.3%
Q2 200230 Sept
EPS$-1.70
Beat 24.4%
Q1 200230 Jun
EPS$1.14
Miss 9.5%
Q4 200131 Mar
EPS$0.81
Miss 5.7%
Q3 200131 Dec
EPS$0.71
Beat 68.9%
Q2 200130 Sept
EPS$1.55
Miss 1.9%
Q1 200130 Jun
EPS$1.25
Beat 14.7%
Q4 200031 Mar
EPS$0.75
Miss 25.8%
Q3 200031 Dec
EPS$1.22
Miss 26.9%
Q2 200030 Sept
EPS$1.20
Miss 11.8%
Q1 200030 Jun
EPS$0.73
Beat 29.7%
Q4 199931 Mar
EPS$0.28
Beat 10.1%

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about PHH

Which members of Congress have traded PHH?
1 member of Congress has disclosed 2 trade in Park Ha Biological Technology Co., Ltd. (PHH) under the STOCK Act: Seth Moulton.
When was PHH most recently disclosed by Congress?
The most recent PHH disclosure was a sale by Seth Moulton on 29 February 2016.
What is the total disclosed congressional trading volume for PHH?
Members of Congress have disclosed approximately $16K in PHH sales (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in PHH?
This PHH page updates as soon as new STOCK Act disclosures are filed for Park Ha Biological Technology Co., Ltd.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.